SCHEMBL27369629

SCHEMBL27369629

CC(C)/C(=N/OCc1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
PPARG P37231 9/20 0.46
PPARA Q07869 8/20 0.46
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
LMNA P02545 2/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
KMT2A Q03164 2/20 0.41
HTT P42858 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
ALDH1A1 P00352 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10147075 0.80 MAPT (0.45) L3MBTL1NPC1RAB9ASMN1; SMN2PPARG
SCHEMBL8915316 0.80 PPARG (0.41) L3MBTL1NPC1RAB9ASMN1; SMN2PPARG
SCHEMBL14627769 0.79 MAPT (0.48) L3MBTL1NPC1RAB9ASMN1; SMN2PPARG
SCHEMBL22548068 0.77 ALDH1A1 (0.43) L3MBTL1NPC1RAB9ASMN1; SMN2PPARG
SCHEMBL13510803 0.77 ALDH1A1 (0.43) L3MBTL1NPC1RAB9ASMN1; SMN2PPARG
SCHEMBL19733323 0.77 L3MBTL1 (0.71) L3MBTL1NPC1RAB9ASMN1; SMN2PPARG
SCHEMBL4451421 0.77 L3MBTL1 (0.71) L3MBTL1NPC1RAB9ASMN1; SMN2PPARG
SCHEMBL11615686 0.77 PPARG (0.49) L3MBTL1NPC1RAB9APPARGPPARA
SCHEMBL2051105 0.76 NPC1 (0.49) L3MBTL1NPC1RAB9ASMN1; SMN2PPARG
SCHEMBL22672464 0.76 POLB (0.44) L3MBTL1RAB9ASMN1; SMN2MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092011-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-05-02 WO disclosed